Literature DB >> 9725826

Characterization of an allele-nonspecific intragenic suppressor in the yeast plasma membrane H+-ATPase gene (Pma1).

A M Maldonado1, N de la Fuente, F Portillo.   

Abstract

We have analyzed the ability of A165V, V169I/D170N, and P536L mutations to suppress pma1 dominant lethal alleles and found that the P536L mutation is able to suppress the dominant lethality of the pma1-R271T, -D378N, -D378E, and -K474R mutant alleles. Genetic and biochemical analyses of site-directed mutants at Pro-536 suggest that this amino acid may not be essential for function but is important for biogenesis of the ATPase. Proteins encoded by dominant lethal pma1 alleles are retained in the endoplasmic reticulum, thus interfering with transport of wild-type Pma1. Immunofluorescence studies of yeast conditionally expressing revertant alleles show that the mutant enzymes are correctly located at the plasma membrane and do not disturb targeting of the wild-type enzyme. We propose that changes in Pro-536 may influence the folding of the protein encoded by a dominant negative allele so that it is no longer recognized and retained as a misfolded protein by the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725826      PMCID: PMC1460317     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  40 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Tight control of the amount of yeast plasma membrane ATPase during changes in growth conditions and gene dosage.

Authors:  P Eraso; A Cid; R Serrano
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

4.  Replacement of the promoter of the yeast plasma membrane ATPase gene by a galactose-dependent promoter and its physiological consequences.

Authors:  A Cid; R Perona; R Serrano
Journal:  Curr Genet       Date:  1987       Impact factor: 3.886

5.  The structure of an antigenic determinant in a protein.

Authors:  I A Wilson; H L Niman; R A Houghten; A R Cherenson; M L Connolly; R A Lerner
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

6.  In vivo glucose activation of the yeast plasma membrane ATPase.

Authors:  R Serrano
Journal:  FEBS Lett       Date:  1983-05-30       Impact factor: 4.124

7.  Yeast plasma membrane ATPase is essential for growth and has homology with (Na+ + K+), K+- and Ca2+-ATPases.

Authors:  R Serrano; M C Kielland-Brandt; G R Fink
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

8.  Genetic analysis of staphylococcal nuclease: identification of three intragenic "global" suppressors of nuclease-minus mutations.

Authors:  D Shortle; B Lin
Journal:  Genetics       Date:  1985-08       Impact factor: 4.562

9.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

10.  Secretory vesicles externalize the major plasma membrane ATPase in yeast.

Authors:  C L Holcomb; W J Hansen; T Etcheverry; R Schekman
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  2 in total

1.  Regulation of yeast H(+)-ATPase by protein kinases belonging to a family dedicated to activation of plasma membrane transporters.

Authors:  A Goossens; N de La Fuente; J Forment; R Serrano; F Portillo
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  Characterization of two second-site mutations preventing wild type protein aggregation caused by a dominant negative PMA1 mutant.

Authors:  Pilar Eraso; Francisco Portillo; María J Mazón
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.